SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of ...
Preliminary evidence suggests that rapid tests like Abbott BinaxNOW and Quidel QuickVue struggle to detect the omicron variant during an individual’s first few days of infection. AzmanL via Getty ...
Last week, QuidelOrtho Corporation QDEL announced the availability of QUICKVUE Influenza + SARS Test. The CLIA-waived, 510(k)–cleared rapid, easy-to-use immunoassay is the latest addition to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback